-
Newborn Screening: Innovative Policies and Technologies to Eliminate the Diagnostic Odyssey (Government Relations Committee)
-
Safety and Efficacy of Bodywide Therapy for Muscular Skeletal Diseases (Musculo-Skeletal Gene and Cell Therapy Committee)
-
Vaccine Nanotechnology for Rapid Response Applications (Nanoagents and Synthetic Formulations Committee)
-
New Advances in Physical Gene Delivery and Nucleic Acid Vectorology (Physical Delivery, Therapeutics, and Vector Development Committee)
-
Hot Topics and Remaining Challenges in RNAi and Oligonucleotide Therapy for 2021 (Oligonucleotide and RNAi Therapeutics Committee)
-
Race to Respiratory Therapies for COVID-19 (Respiratory and GI Tract Gene and Cell Therapy Committee)
-
RNA Therapies for Neurologic and Ophthalmic Disorders (Neurologic and Ophthalmic Gene and Cell Therapy Committee)